aminolevulinic acid hydrochloride
Sponsors
Roswell Park Cancer Institute, National Cancer Institute (NCI), Laser and Skin Surgery Center of New York, Abramson Cancer Center at Penn Medicine, Dartmouth-Hitchcock Medical Center
Conditions
Actinic CheilitisActinic KeratosisBreast CancerBreast Neoplasm FemaleHead and Neck CancerLeukemiaLymphomaNon-melanomatous Skin Cancer
Early Phase 1
Phase 1
Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia
TerminatedNCT00571558
Start: 2008-03-31End: 2010-11-30Updated: 2014-10-09
Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors
CompletedNCT00978081
Start: 2009-01-31End: 2016-11-30Updated: 2019-04-23
Phase 2
Photodynamic Therapy in Treating Patients With Skin Cancer
CompletedNCT00002963
Start: 1993-11-30End: 2007-06-30Updated: 2013-01-31
Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia
CompletedNCT00054171
Start: 1999-02-28Updated: 2013-01-31
Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer
NCT00747903
Start: 2008-02-29Target: 20Updated: 2014-01-10
A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients
Not yet recruitingNCT06907485
Start: 2026-08-01End: 2028-08-01Target: 20Updated: 2026-01-21
Phase 3
Phase 4
Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis
CompletedNCT02409732
Start: 2015-04-30End: 2017-07-31Updated: 2018-10-23
Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel
NCT02647151
Start: 2015-12-31End: 2016-03-31Target: 50Updated: 2016-01-06